Guideline
Good Publication Practice (GPP) guidelines
To increase the focus on integrity and transparency in industry-sponsored publication planning and development in today’s environment.
This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmaceutical, medical device, diagnostics, and biotechnology companies. The recommendations are designed to help individuals and organizations maintain ethical and transparent publication practices and comply with legal and regulatory requirements. These recommendations cover publications in peer reviewed journals and presentations (oral or poster) at scientific congresses.
Reference of the resource
Chris Graf, Wendy P. Battisti, Dan Bridges, Victoria Bruce-Winkler, Joanne M. Conaty, John M. Ellison, Elizabeth A. Field, James A. Gurr, Mary-Ellen Marx, Mina Patel, Carol Sanes-Miller, Yvonne E. Yarker, for
the International Society for Medical Publication Professionals, "Good publication practice for communicating company sponsored medical research: the GPP2 guidelines", International Society of Medical Publication Professionals, BMJ, 2009;339:b4330, doi: 10.1136/bmj.b4330.
